<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>04711155865890</udiDi>
    <basicUdiDi>B-04711155865890</basicUdiDi>
    <tradeName>HYAJOINT</tradeName>
    <deviceName>Hyaluronate Synovial Fluid Supplement</deviceName>
    <manufacturerName>SciVision Biotech Inc.</manufacturerName>
    <manufacturerSrn>TW-MF-000019744</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>HJ-025S</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-25T07:38:15.329Z</lastUpdated>
  </row>
  <row>
    <udiDi>04711155865661</udiDi>
    <basicUdiDi>B-04711155865661</basicUdiDi>
    <tradeName>HYAJOINT Plus</tradeName>
    <deviceName>Hyaluronate Synovial Fluid Supplement</deviceName>
    <manufacturerName>SciVision Biotech Inc.</manufacturerName>
    <manufacturerSrn>TW-MF-000019744</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>HP-030S</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-25T07:38:14.546Z</lastUpdated>
  </row>
</eudamedExport>